P2RX7 functions as a putative biomarker of gastric cancer and contributes to worse prognosis

Exp Biol Med (Maywood). 2019 Jun;244(9):734-742. doi: 10.1177/1535370219846492. Epub 2019 May 1.

Abstract

The mechanism of gastric cancer is highly complex, accompanied by a variety of genetic abnormalities. It is of great significance to elucidate the pathogenesis of gastric cancer, find its markers and therapeutic targets in the fight against this fatal disease. In this study, we identified P2RX7 as a putative target of gastric cancer, which was overexpressed in gastric cancer tissues and had relationship with worse prognosis. We also elucidated the roles of P2RX7 on the growth and metastasis of gastric cancer cells, and explored the relationship between it and ERK1/2 pathway, Akt pathway, and epithelial-mesenchymal transition. Our findings begin to offer useful insights into the mechanism of gastric cancer progression and provide clues to novel therapy strategies.

Keywords: P2RX7; gastric cancer; metastasis; proliferation.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / metabolism
  • Blotting, Western
  • Cell Line, Tumor
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • MAP Kinase Signaling System
  • Male
  • Middle Aged
  • Prognosis
  • Real-Time Polymerase Chain Reaction
  • Receptors, Purinergic P2X7 / analysis
  • Receptors, Purinergic P2X7 / metabolism*
  • Stomach / chemistry
  • Stomach Neoplasms / chemistry
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / mortality
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • P2RX7 protein, human
  • Receptors, Purinergic P2X7